Michael Garron Hospital

Toronto, Ontario M4C 3E7

0 studies enrolling now · 4 studies all time

What they study most

Antimicrobial, Bacteremia, Breast Adenocarcinoma, Breast Ductal Carcinoma In Situ, Critically Ill, Hormone Receptor Positive, Intensive Care, Invasive Breast Carcinoma, Mortality, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma, Sepsis

Studies at this site

• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer — Running, not enrolling
• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) — Running, not enrolling
• Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia — Running, not enrolling
• Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness — Completed